Benjamin Halladay - Chief Financial Officer at Esperion Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
ESPR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Benjamin Halladay - trading volume in the past year for Esperion Therapeutics, Inc.

Holdings reported by Benjamin Halladay for Esperion Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 241K $583K $2.42 Dec 17, 2024 Direct
Stock Option (right to buy) 200K Mar 14, 2024 Direct Common Stock

Transactions reported by Benjamin Halladay for Esperion Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.